Direct Observation Study of Kratom Product Effects Among Regular Consumers
Johns Hopkins University · with University of Florida, National Institute on Drug Abuse (NIDA) · NCT06089980
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 21+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 22
- US sites recruiting
- 1
- Study start
- April 1, 2024
- Record last updated
- January 23, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this observational clinical study is to is to learn more about how commercial kratom products affect healthy adults who consume them regularly. The main questions it aims to answer are:
- What are the acute physiological, subjective, and cognitive effects of kratom following participant self-administration of a single oral dose of the participants usual kratom product at the participants typical dose?
- What are the physiological, subjective, and cognitive effects associated with kratom product discontinuation among adults who use regularly?
- What are the pharmacokinetics of kratom products consumed by adults who use regularly? On the first study day: Under direct observation, participants will self-administer a single oral dose of the participants own commercial kratom product that that is regularly taken and will consume it at the participants self-selected typical dose/serving. Following this, serial blood draws and urine collection will occur along with administration of validated questionnaires, tests, and continual monitoring. After this first study day, participants will no longer be permitted to use any of the participants kratom product during the study. On study nights/days 2-3: participants will reside a clinical research unit and be observed and evaluated for kratom withdrawal syndrome.
Being studied: Effects from acute kratom exposure
Conditions: Kratom Pharmacokinetics; Kratom Pharmacodynamics; Kratom
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
INCLUSION CRITERIA
- >21 years
- reporting kratom use >5 times per week for >3 months prior to study screening
- English language proficiency
- Willingness to provide requested samples of the kratom product being currently taken
EXCLUSION CRITERIA
- Reports any acute adverse, unexpected, or otherwise sudden health event related to the typical kratom product dose that occurred within 30 days of screening
- Having ever sought medical attention for an acute adverse health event as a result of taking any kratom product.
- Cannot or will not provide kratom product samples in the form of an unopened package of kratom that is clearly labeled with at least the product and vendor name.
- Self-reports using kratom products by any other route than orally swallowing.
- Current physical dependence on alcohol, benzodiazepines, or opioids
- Reports use of fentanyl within the past month and/or has a fentanyl positive drug screen.
- Discordance between self-reported substance use and drug screen results obtained during screening.
- Lifetime or current psychotic disorder
- Current untreated major depressive or bipolar disorder
- Pregnancy or nursing
- Physical, psychiatric, or environmental conditions considered by study team to increase risk or undue burden (e.g., untreated hypertension, high BMI, etc.).
Recruiting US locations
Johns Hopkins University
Baltimore, MD 21224
Site contact: Kirsten E Smith, Ph.D. · 865-418-8177 · ksmit398@jh.edu
Study contacts (from the official record)
- Kirsten E Smith, Ph.D. · 865-418-8177 · ksmit398@jh.edu
- Naftali Zeilinger, B.A. · 410-550-0490 · nzeilin1@jh.edu
Similar studies in Maryland
All healthy volunteers studies in Maryland →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
AstraZeneca
- Location
- Brooklyn, MD + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Role of Metal Ion Transporter ZIP8 in Alcohol-Related Behaviors
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Location
- Bethesda, MD
- Eligibility basics
- Ages 21–60
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Study of Intravenous ZMA001 in Healthy Subjects
National Heart, Lung, and Blood Institute (NHLBI)
- Location
- Bethesda, MD
- Eligibility basics
- Ages 18–60
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
The Impact of Product Formulation on the Pharmacokinetics and Pharmacodynamics of Cannabis Edibles
Johns Hopkins University
- Location
- Baltimore, MD
- Eligibility basics
- Ages 21–55